Skip to main content

Advertisement

Table 5 Associations between vertebral fracture and lung function according to severity of fracture

From: Cross-sectional associations between prevalent vertebral fracture and pulmonary function in the sixth Tromsø study

  Pulmonary function (mean (SD) or (SE))
  Men Women
  No vertebral fracture (n=771) Vertebral fracture, moderate (n=66) Vertebral fracture, severe (n=55) Pmoderatea Pseverea No vertebral fracture (n=1079) Vertebral fracture, moderate (n=80) Vertebral fracture, severe (n=81) Pmoderatea Pseverea
FVC% predictedb 98.2 (15.3) 96.8 (17.7) 97.7 (17.6) 0.479 0.837 101.2 (15.8) 103.4 (18.3) 101.0 (17.9) 0.238 0.896
FEV1% predictedb 88.9 (16.9) 86.1 (20.5) 85.0 (22.5) 0.218 0.111 93.1 (17.4) 94.9 (20.7) 91.7 (21.0) 0.352 0.526
FEV1/FVC% predicteda 90.6 (10.8) 88.5 (11.7) 86.2 (14.5) 0.134 0.004 92.0 (9.1) 91.1 (10.5) 90.1 (10.4) 0.441 0.078
Adjustedc values (n=665) (n=61) (n=44)    (n=800) (n=56) (n=48)   
FVC (liter (SE)) 4.22 (0.024) 4.20 (0.080) 4.26 (0.095) 0.827 0.714 2.99 (0.015) 3.10 (0.057) 2.90 (0.064) 0.056 0.209
FEV1 (liter (SE)) 3.08 (0.021) 3.02 (0.069) 3.10 (0.083) 0.441 0.847 2.21 (0.013) 2.31 (0.050) 2.16 (0.056) 0.054 0.373
FEV1/FVC (SE) 0.73 (0.003) 0.72 (0.010) 0.73 (0.012) 0.215 0.821 0.74 (0.002) 0.75 (0.009) 0.74 (0.010) 0.402 0.973
  1. The Tromsø Study 2007-08.
  2. aVersus no fracture.
  3. bEquation from Langhammer et al. [27].
  4. cAdjusted for age, smoking habits, height, weight, physical inactivity, cardiovascular disease, lung disease, corticosteroids, hip BMD, hormones for menopause (women).